Literature DB >> 3123693

Fetal valproate syndrome: is there a recognisable phenotype?

R M Winter1, D Donnai, J Burn, S M Tucker.   

Abstract

Four infants who were exposed to sodium valproate or valproic acid during pregnancy are described. Common facial features in the three surviving infants include epicanthic folds, a flat nasal bridge, a broad nasal base, anteverted nostrils, a shallow philtrum, and a thin upper lip with a thick lower lip. Ridging of the metopic suture, congenital heart defect, postaxial polydactyly, and hypospadias were additional features in individual cases. In agreement with previous authors, we feel that there is a distinctive 'fetal valproate' phenotype.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3123693      PMCID: PMC1050348          DOI: 10.1136/jmg.24.11.692

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  1 in total

1.  Possible teratogenicity of valproic acid.

Authors:  M R Gomez
Journal:  J Pediatr       Date:  1981-03       Impact factor: 4.406

  1 in total
  18 in total

Review 1.  Developmental neuropathology of environmental agents.

Authors:  Lucio G Costa; Michael Aschner; Annabella Vitalone; Tore Syversen; Offie Porat Soldin
Journal:  Annu Rev Pharmacol Toxicol       Date:  2004       Impact factor: 13.820

2.  Exposure to Sodium Valproate during Pregnancy: Facial Features and Signs of Autism.

Authors:  Rachel Stadelmaier; Hanah Nasri; Curtis K Deutsch; Margaret Bauman; Anne Hunt; Christopher J Stodgell; Jane Adams; Lewis B Holmes
Journal:  Birth Defects Res       Date:  2017-06-21       Impact factor: 2.344

Review 3.  Dysmorphology demystified.

Authors:  William Reardon; Dian Donnai
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-05       Impact factor: 5.747

4.  Fetal valproate phenotype is recognisable by mid pregnancy.

Authors:  F Serville; D Carles; S Guibaud; D Dallay
Journal:  J Med Genet       Date:  1989-05       Impact factor: 6.318

5.  Fetal valproate syndrome.

Authors:  J Clayton-Smith; D Donnai
Journal:  J Med Genet       Date:  1995-09       Impact factor: 6.318

Review 6.  Valproic acid in epilepsy : pregnancy-related issues.

Authors:  Pierre Genton; Franck Semah; Eugen Trinka
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

7.  A clinical study of 57 children with fetal anticonvulsant syndromes.

Authors:  S J Moore; P Turnpenny; A Quinn; S Glover; D J Lloyd; T Montgomery; J C Dean
Journal:  J Med Genet       Date:  2000-07       Impact factor: 6.318

8.  Omphalocele in a newborn baby exposed to sodium valproate in utero.

Authors:  T Boussemart; D Bonneau; G Levard; M Berthier; D Oriot
Journal:  Eur J Pediatr       Date:  1995-03       Impact factor: 3.183

9.  Malformations, withdrawal manifestations, and hypoglycaemia after exposure to valproate in utero.

Authors:  E Thisted; F Ebbesen
Journal:  Arch Dis Child       Date:  1993-09       Impact factor: 3.791

10.  Risk of hypospadias in newborn infants exposed to valproic acid during the first trimester of pregnancy: a case-control study in Spain.

Authors:  Elvira Rodríguez-Pinilla; Consuelo Mejías; David Prieto-Merino; Paloma Fernández; María L Martínez-Frías
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.